title: Origins of hyperphenylalaninemia in Israel.
abstract: Mutations and polymorphisms at the phenylalanine hydroxylase (PAH) gene were used to study the genetic diversity of the Jewish and Palestinian Arab populations in Israel. PAH mutations are responsible for a large variety of hyperphenylalaninemias (HPAs), ranging from the autosomal recessive disease phenylketonuria to various degrees of nonclinical HPA. Seventy-two Jewish and 36 Palestinian Arab families with various HPAs, containing 115 affected genotypes, were studied by haplotype analysis, screening for previously known PAH lesions and a search for novel mutations. Forty-one PAH haplotypes were observed in this sample. Four mutations previously identified in Europe (IVS10nt546, R261Q, R408W and R158Q) were found, and were associated with the same haplotypes as in Europe, indicating possible gene flow from European populations into the Jewish and Palestinian gene pools. Of particular interest is a PAH allele with the IVS10nt546 mutation and haplotype 6, that might have originated in Italy more than 3,000 years ago and spread during the expansion of the Roman Empire. These results, together with previous identification of three PAH mutations unique to Palestinian Arabs [IVSnt2, Edel(197-205) and R270S], indicate that the relatively high genetic diversity of the Jewish and Palestinian populations reflects, in addition to genetic events unique to these communities, some gene flow from neighboring and conquering populations.
authors.affiliation: Department of Human Genetics, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel.
authors.forename: S
authors.initials: S
authors.lastname: Kleiman
authors.forename: S
authors.initials: S
authors.lastname: Avigad
authors.forename: L
authors.initials: L
authors.lastname: Vanagaite
authors.forename: A
authors.initials: A
authors.lastname: Shmuelevitz
authors.forename: M
authors.initials: M
authors.lastname: David
authors.forename: R C
authors.initials: RC
authors.lastname: Eisensmith
authors.forename: N
authors.initials: N
authors.lastname: Brand
authors.forename: G
authors.initials: G
authors.lastname: Schwartz
authors.forename: F
authors.initials: F
authors.lastname: Rey
authors.forename: A
authors.initials: A
authors.lastname: Munnich
authors.forename: S L
authors.initials: SL
authors.lastname: Woo
authors.forename: Y
authors.initials: Y
authors.lastname: Shiloh
mesh_terms: D000592:Amino Acid Metabolism, Inborn Errors / Q000097:blood / Q000453:epidemiology / Q000235:genetics*; D004252:DNA Mutational Analysis; D014644:Genetic Variation; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D007557:Israel / Q000453:epidemiology; D007585:Jews / Q000235:genetics*; D008877:Middle East / Q000208:ethnology; D017720:Molecular Epidemiology; D010649:Phenylalanine / Q000097:blood*; D010651:Phenylalanine Hydroxylase / Q000235:genetics*; D010661:Phenylketonurias / Q000453:epidemiology / Q000235:genetics; D017354:Point Mutation; D012150:Polymorphism, Restriction Fragment Length
chemical_list: D010649:Phenylalanine; D010651:Phenylalanine Hydroxylase